Based on these results, we speculate that the importance of MLH1 methylation for tumor classification may be due to variation in the causes of methylation in many cancer-specific genes, including MLH1, and to the distinct mechanisms underlying loss of HLA class I expression and enhanced immune surveillance in MLH1-M tumors. This evidence concerns the gene MLH1 and cancer.